The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Lipid Accumulation and Chronic Kidney Disease
Open accessAbstract
Obesity and hyperlipidemia are the most prevalent independent risk factors of chronic kidney disease (CKD), suggesting that lipid accumulation in the renal parenchyma is detrimental to renal function. Non-esterified fatty acids (also known as free fatty acids, FFA) are especially harmful to the kidneys. A concerted, increased FFA uptake due to high fat diets, overexpression of fatty acid uptake systems such as the CD36 scavenger receptor and the fatty acid transport proteins, and a reduced β-oxidation rate underlie the intracellular lipid accumulation in non-adipose tissues. FFAs in excess can damage podocytes, proximal tubular epithelial cells and the tubulointerstitial tissue through various mechanisms, in particular by boosting the production of reactive oxygen species (ROS) and lipid peroxidation, promoting mitochondrial damage and tissue inflammation, which result in glomerular and tubular lesions. Not all lipids are bad for the kidneys: polyunsaturated fatty acids (PUFA) such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) seem to help lag the progression of chronic kidney disease (CKD). Lifestyle interventions, especially dietary adjustments, and lipid-lowering drugs can contribute to improve the clinical outcome of patients with CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60739-3 · Cited by 2,479
Klahr, S., Levey, A. S., Beck, G. J., Caggiula, A. W., Hunsicker, L., Kusek, J. W., & Striker, G. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403313301301 · Cited by 2,328
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797
Kang, H. M., Ahn, S. H., Choi, P., Ko, Y.-A., Han, S. H., Chinga, F., Park, A. S. D., Tao, J., Sharma, K., Pullman, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3762 · Cited by 1,555
Angiogenesis and Inflammation in Peritoneal Dialysis: The Role of Adipocytes
Shi, J., Yu, M., & Sheng, M. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000476017 · Cited by 1,403
Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., & Wahli, W. (1992) · Cell · doi:10.1016/0092-8674(92)90031-7 · Cited by 1,376
Obesity-related glomerulopathy: An emerging epidemic
Kambham, N., Markowitz, G. S., Valeri, A. M., Lin, J., & D'Agati, V. D. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041498.x · Cited by 1,286
Schoonjans, K., Staels, B., & Auwerx, J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42003-6 · Cited by 1,216
The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene
Fajas, L., Auboeuf, D., Raspé, E., Schoonjans, K., Lefebvre, A.-M., Saladin, R., Najib, J., Laville, M., Fruchart, J.-C., Deeb, S., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18779 · Cited by 1,188
Chronic Hypoxia and Tubulointerstitial Injury: A Final Common Pathway to End-Stage Renal Failure
Nangaku, M. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005070757 · Cited by 1,135
LIPID NEPHROTOXICITY IN CHRONIC PROGRESSIVE GLOMERULAR AND TUBULO-INTERSTITIAL DISEASE
Moorhead, J. F., El-Nahas, M., Chan, M. K., & Varghese, Z. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91513-6 · Cited by 1,070
Febbraio, M., Podrez, E. A., Smith, J. D., Hajjar, D. P., Hazen, S. L., Hoff, H. F., Sharma, K., & Silverstein, R. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9259 · Cited by 1,044
Wu, Z., Rosen, E. D., Brun, R., Hauser, S., Adelmant, G., Troy, A. E., McKeon, C., Darlington, G. J., & Spiegelman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80306-8 · Cited by 1,015
Yeh, W. C., Cao, Z., Classon, M., & McKnight, S. L. (1995) · Genes & Development · doi:10.1101/gad.9.2.168 · Cited by 935
Holdaas, H., Fellström, B., Jardine, A. G., Holme, I., Nyberg, G., Fauchald, P., Grönhagen-Riska, C., Madsen, S., Neumayer, H.-H., Cole, E., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13638-0 · Cited by 919
Zhang, D.-E., Zhang, P., Wang, N.-D., Hetherington, C. J., Darlington, G. J., & Tenen, D. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.569 · Cited by 910
Adipogenesis: From Stem Cell to Adipocyte
Tang, Q. Q., & Lane, M. D. (2012) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052110-115718 · Cited by 902
Oxidative stress in chronic kidney disease
Daenen, K., Andries, A., Mekahli, D., Van Schepdael, A., Jouret, F., & Bammens, B. (2019) · Pediatric Nephrology · doi:10.1007/s00467-018-4005-4 · Cited by 882
Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein
Schaffer, J. E., & Lodish, H. F. (1994) · Cell · doi:10.1016/0092-8674(94)90252-6 · Cited by 872
Focal Segmental Glomerulosclerosis
D'Agati, V. D., Kaskel, F. J., & Falk, R. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1106556 · Cited by 825
US Renal Data System 2011 Annual Data Report
Collins, A. J., Foley, R. N., Chavers, B., Gilbertson, D., Herzog, C., Johansen, K., Kasiske, B., Kutner, N., Liu, J., St. Peter, W., et al. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.11.015 · Cited by 820
Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis
D'Agati, V. D., Chagnac, A., de Vries, A. P. J., Levi, M., Porrini, E., Herman-Edelstein, M., & Praga, M. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.75 · Cited by 716
Lemberger, T., Desvergne, B., & Wahli, W. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.335 · Cited by 712
Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy
Herman-Edelstein, M., Scherzer, P., Tobar, A., Levi, M., & Gafter, U. (2014) · Journal of Lipid Research · doi:10.1194/jlr.p040501 · Cited by 645
Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study
Yamagata, K., Ishida, K., Sairenchi, T., Takahashi, H., Ohba, S., Shiigai, T., Narita, M., & Koyama, A. (2007) · Kidney International · doi:10.1038/sj.ki.5002017 · Cited by 624
Birkenmeier, E. H., Gwynn, B., Howard, S., Jerry, J., Gordon, J. I., Landschulz, W. H., & McKnight, S. L. (1989) · Genes & Development · doi:10.1101/gad.3.8.1146 · Cited by 613
The emerging safety profile of JAK inhibitors in rheumatic disease
Winthrop, K. L. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.23 · Cited by 590
Nahin, R. L., Barnes, P. M., Stussman, B. J., & Bloom, B. E. (2009) · PubMed · Cited by 583
Wolfrum, C., Borrmann, C. M., Börchers, T., & Spener, F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051619898 · Cited by 503
Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease
de Vries, A. P. J., Ruggenenti, P., Ruan, X. Z., Praga, M., Cruzado, J. M., Bajema, I. M., D'Agati, V. D., Lamb, H. J., Barlovic, D. P., Hojs, R., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70065-8 · Cited by 500
Association Between Body Mass Index and CKD in Apparently Healthy Men
Gelber, R. P., Kurth, T., Kausz, A. T., Manson, J. E., Buring, J. E., Levey, A. S., & Gaziano, J. M. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.08.015 · Cited by 460
Fatty acid-binding proteins – insights from genetic manipulations
Haunerland, N. H., & Spener, F. (2004) · Progress in Lipid Research · doi:10.1016/j.plipres.2004.05.001 · Cited by 444
Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonists
Grommes, C., Landreth, G. E., & Heneka, M. T. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01509-8 · Cited by 440
Obesity and Prevalent and Incident CKD: The Hypertension Detection and Follow-Up Program
Kramer, H., Luke, A., Bidani, A., Cao, G., Cooper, R., & McGee, D. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.06.007 · Cited by 414
Bachelez, H., van de Kerkhof, P. C. M., Strohal, R., Kubanov, A., Valenzuela, F., Lee, J.-H., Yakusevich, V., Chimenti, S., Papacharalambous, J., Proulx, J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62113-9 · Cited by 410
Zeller, K., Whittaker, E., Sullivan, L., Raskin, P., & Jacobson, H. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101103240202 · Cited by 409
Berger, J., Bailey, P., Biswas, C., Cullinan, C. A., Doebber, T. W., Hayes, N. S., Saperstein, R., Smith, R. G., & Leibowitz, M. D. (1996) · Endocrinology · doi:10.1210/endo.137.10.8828476 · Cited by 391
Jiang, T., Wang, Z., Proctor, G., Moskowitz, S., Liebman, S. E., Rogers, T., Lucia, M. S., Li, J., & Levi, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500801200 · Cited by 387
Self-citationMechanisms for the Hypotriglyceridemic Effect of Marine Omega-3 Fatty Acids
Davidson, M. H. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.024 · Cited by 374
Stremmel, W., Strohmeyer, G., Borchard, F., Kochwa, S., & Berk, P. D. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.4 · Cited by 351
Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea
Sato, H., Genet, C., Strehle, A., Thomas, C., Lobstein, A., Wagner, A., Mioskowski, C., Auwerx, J., & Saladin, R. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.130 · Cited by 340
Harrison, C. N., Schaap, N., Vannucchi, A. M., Kiladjian, J.-J., Tiu, R. V., Zachee, P., Jourdan, E., Winton, E., Silver, R. T., Schouten, H. C., et al. (2017) · The Lancet Haematology · doi:10.1016/s2352-3026(17)30088-1 · Cited by 339
SLC27 fatty acid transport proteins
Anderson, C. M., & Stahl, A. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.07.010 · Cited by 336
Sun, L., Halaihel, N., Zhang, W., Rogers, T., & Levi, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110650200 · Cited by 333
Physiological properties and functions of intracellular fatty acid-binding proteins
Coe, N. R., & Bernlohr, D. A. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(97)00205-1 · Cited by 329
Goraya, N., Simoni, J., Jo, C., & Wesson, D. E. (2012) · Kidney International · doi:10.1038/ki.2011.313 · Cited by 321
Yamamoto, T., Takabatake, Y., Takahashi, A., Kimura, T., Namba, T., Matsuda, J., Minami, S., Kaimori, J.-Y., Matsui, I., Matsusaka, T., et al. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016070731 · Cited by 307
Stahl, A., Evans, J. G., Pattel, S., Hirsch, D., & Lodish, H. F. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00143-0 · Cited by 259
Soy Protein Intake, Cardiorenal Indices, and C-Reactive Protein in Type 2 Diabetes With Nephropathy
Azadbakht, L., Atabak, S., & Esmaillzadeh, A. (2008) · Diabetes Care · doi:10.2337/dc07-2065 · Cited by 257
Menon, V., Kopple, J. D., Wang, X., Beck, G. J., Collins, A. J., Kusek, J. W., Greene, T., Levey, A. S., & Sarnak, M. J. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.08.009 · Cited by 256
AMPK Mediates the Initiation of Kidney Disease Induced by a High-Fat Diet
Declèves, A.-E., Mathew, A. V., Cunard, R., & Sharma, K. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011010026 · Cited by 251
FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase
Falcon, A., Doege, H., Fluitt, A., Tsang, B., Watson, N., Kay, M. A., & Stahl, A. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00226.2010 · Cited by 249
Ohgami, N., Nagai, R., Ikemoto, M., Arai, H., Kuniyasu, A., Horiuchi, S., & Nakayama, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006545200 · Cited by 244
Isnard Bagnis, C., Deray, G., Baumelou, A., Le Quintrec, M., & Vanherweghem, J. L. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.02.009 · Cited by 244
Farnesoid X Receptor Modulates Renal Lipid Metabolism, Fibrosis, and Diabetic Nephropathy
Jiang, T., Wang, X. X., Scherzer, P., Wilson, P., Tallman, J., Takahashi, H., Li, J., Iwahashi, M., Sutherland, E., Arend, L., et al. (2007) · Diabetes · doi:10.2337/db06-1642 · Cited by 236
Cellular uptake of fatty acids driven by the ER-localized acyl-CoA synthetase FATP4
Milger, K., Herrmann, T., Becker, C., Gotthardt, D., Zickwolf, J., Ehehalt, R., Watkins, P. A., Stremmel, W., & Füllekrug, J. (2006) · Journal of Cell Science · doi:10.1242/jcs.03280 · Cited by 233
FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity
Wang, X. X., Wang, D., Luo, Y., Myakala, K., Dobrinskikh, E., Rosenberg, A. Z., Levi, J., Kopp, J. B., Field, A., Hill, A., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017020222 · Cited by 222
Susztak, K., Ciccone, E., McCue, P., Sharma, K., & Böttinger, E. P. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020045 · Cited by 214
G Protein-Coupled Bile Acid Receptor TGR5 Activation Inhibits Kidney Disease in Obesity and Diabetes
Wang, X. X., Edelstein, M. H., Gafter, U., Qiu, L., Luo, Y., Dobrinskikh, E., Lucia, S., Adorini, L., D’Agati, V. D., Levi, J., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014121271 · Cited by 213
The Long-Term Outcome of Patients with IgA Nephropathy Treated with Fish Oil in a Controlled Trial
DONADIO, J. V., GRANDE, J. P., BERGSTRALH, E. J., DART, R. A., LARSON, T. S., & SPENCER, D. C. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1081772 · Cited by 209
Diets and enteral supplements for improving outcomes in chronic kidney disease
Kalantar-Zadeh, K., Cano, N. J., Budde, K., Chazot, C., Kovesdy, C. P., Mak, R. H., Mehrotra, R., Raj, D. S., Sehgal, A. R., Stenvinkel, P., et al. (2011) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.60 · Cited by 192
Fenofibrate, a PPARα agonist, has renoprotective effects in mice by enhancing renal lipolysis
Tanaka, Y., Kume, S., Araki, S.-I., Isshiki, K., Chin-Kanasaki, M., Sakaguchi, M., Sugimoto, T., Koya, D., Haneda, M., Kashiwagi, A., et al. (2011) · Kidney International · doi:10.1038/ki.2010.530 · Cited by 190
Wang, X. X., Jiang, T., Shen, Y., Caldas, Y., Miyazaki-Anzai, S., Santamaria, H., Urbanek, C., Solis, N., Scherzer, P., Lewis, L., et al. (2010) · Diabetes · doi:10.2337/db10-0019 · Cited by 186
Baranova, I. N., Vishnyakova, T. G., Bocharov, A. V., Kurlander, R., Chen, Z., Kimelman, M. L., Remaley, A. T., Csako, G., Thomas, F., Eggerman, T. L., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m405009200 · Cited by 184
Impaired β-Oxidation and Altered Complex Lipid Fatty Acid Partitioning with Advancing CKD
Afshinnia, F., Rajendiran, T. M., Soni, T., Byun, J., Wernisch, S., Sas, K. M., Hawkins, J., Bellovich, K., Gipson, D., Michailidis, G., et al. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017030350 · Cited by 183
L-FABP directly interacts with PPARα in cultured primary hepatocytes
Hostetler, H. A., McIntosh, A. L., Atshaves, B. P., Storey, S. M., Payne, H. R., Kier, A. B., & Schroeder, F. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m900058-jlr200 · Cited by 169
Khatri, M., Moon, Y. P., Scarmeas, N., Gu, Y., Gardener, H. E., Cheung, K., Wright, C. B., Sacco, R. L., Nickolas, T. L., & Elkind, M. S. V. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01080114 · Cited by 168
The Evolving Understanding of the Contribution of Lipid Metabolism to Diabetic Kidney Disease
Stadler, K., Goldberg, I. J., & Susztak, K. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0611-8 · Cited by 165
A role for fatty acids and liver fatty acid binding protein in peroxisome proliferation?
Issemann, I., Prince, R., Tugwood, J., & Green, S. (1992) · Biochemical Society Transactions · doi:10.1042/bst0200824 · Cited by 164
CD36 Mediated Fatty Acid-Induced Podocyte Apoptosis via Oxidative Stress
Hua, W., Huang, H.-Z., Tan, L.-T., Wan, J.-M., Gui, H.-B., Zhao, L., Ruan, X.-Z., Chen, X.-M., & Du, X.-G. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127507 · Cited by 163
Structural organization of the gene for human CD36 glycoprotein.
Armesilla, A. L., & Vega, M. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32263-9 · Cited by 163
Dietary Patterns and Risk of Death and Progression to ESRD in Individuals With CKD: A Cohort Study
Gutiérrez, O. M., Muntner, P., Rizk, D. V., McClellan, W. M., Warnock, D. G., Newby, P. K., & Judd, S. E. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.02.013 · Cited by 162
CD36 Regulates Oxidative Stress and Inflammation in Hypercholesterolemic CKD
Okamura, D. M., Pennathur, S., Pasichnyk, K., Accent]pez-Guisa, J. A. A. M. L. A., Collins, S., Febbraio, M., Heinecke, J. W., & Eddy, A. A. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008010009 · Cited by 159
Very Low Protein Diet Reduces Indoxyl Sulfate Levels in Chronic Kidney Disease
Marzocco, S., Piaz, F. D., Micco, L. D., Torraca, S., Sirico, M. L., Tartaglia, D., Autore, G., & Iorio, B. R. D. (2013) · Blood Purification · doi:10.1159/000346628 · Cited by 155
Systemic and renal lipids in kidney disease development and progression
WAHL, P. W., Ducasa, G. M., & Fornoni, A. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00375.2015 · Cited by 152
Munkhaugen, J., Lydersen, S., Widerøe, T., & Hallan, S. I. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.03.023 · Cited by 150
Oxidative Stress in Chronic Kidney Disease
Scholze, A., Jankowski, J., Pedraza‐Chaverrí, J., & Evenepoel, P. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8375186 · Cited by 144
Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease
Bertocchio, J., Warnock, D. G., & Jaisser, F. (2011) · Kidney International · doi:10.1038/ki.2011.48 · Cited by 143
Masyuk, A. I., Huang, B. Q., Radtke, B. N., Gajdos, G. B., Splinter, P. L., Masyuk, T. V., Gradilone, S. A., & LaRusso, N. F. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00383.2012 · Cited by 143
Transcriptional activation of adipogenesis
Wu, Z., Puigserver, P., & Spiegelman, B. M. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00037-x · Cited by 138
Oxidative stress in chronic kidney disease.
Modaresi, A., Nafar, M., & Sahraei, Z. (2015) · Iranian Journal of Kidney Diseases · Cited by 130
Megalin-Mediated Tubuloglomerular Alterations in High-Fat Diet–Induced Kidney Disease
Kuwahara, S., Hosojima, M., Kaneko, R., Aoki, H., Nakano, D., Sasagawa, T., Kabasawa, H., Kaseda, R., Yasukawa, R., Ishikawa, T., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015020190 · Cited by 126
Down-regulation and antiproliferative role of C/EBPalpha in lung cancer.
Halmos, B., Huettner, C. S., Kocher, O. N., Ferenczi, K., Karp, D. D., & Tenen, D. G. (2002) · PubMed · Cited by 124
Metabolic Substrates, Cellular Energy Production, and the Regulation of Proximal Tubular Transport
Mandel, L. J. (1985) · Annual Review of Physiology · doi:10.1146/annurev.ph.47.030185.000505 · Cited by 124
JAK inhibition and progressive kidney disease
Brosius, F. C., & He, C. (2014) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000079 · Cited by 124
Jiang, T., Liebman, S. E., Lucia, M. S., Li, J., & Levi, M. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00733.x · Cited by 123
Saiki, A., Nagayama, D., Ohira, M., Endoh, K., Ohtsuka, M., Koide, N., Oyama, T., Miyashita, Y., & Shirai, K. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803009 · Cited by 123
Impact of Dyslipidemia in End-Stage Renal Disease
Prichard, S. S. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000081698.10331.83 · Cited by 123
Miyamoto, S., Hsu, C., Hamm, G. R., Darshi, M., Diamond-Stanic, M. K., Declèves, A., Slater, L., Pennathur, S., Stauber, J., Dorrestein, P. C., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.03.033 · Cited by 123
Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study
Appel, G. B., Radhakrishnan, J., Avram, M. M., DeFronzo, R. A., Escobar‐Jiménez, F., Campos, M. M., Burgess, E. D., Hille, D. A., Dickson, T. Z., Shahinfar, S., et al. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1402 · Cited by 119
Obesity-Related Glomerulopathy in China: A Case Series of 90 Patients
Chen, H., Li, S., Chen, H., Wang, Q., Leishi, L., & Liu, Z.-H. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.02.303 · Cited by 106
Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment
Xu, T., Sheng, Z., & Yao, L. (2017) · Frontiers of Medicine · doi:10.1007/s11684-017-0570-3 · Cited by 106
Erratum: The emerging safety profile of JAK inhibitors in rheumatic disease
Winthrop, K. L. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.51 · Cited by 105
CD36 and Na/K-ATPase-α1 Form a Proinflammatory Signaling Loop in Kidney
Kennedy, D. J., Chen, Y., Huang, W., Viterna, J., Liu, J., Westfall, K., Tian, J., Bartlett, D. J., Tang, W. H. W., Xie, Z., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.112.198770 · Cited by 101
Krikken, J. A., Lely, A. T., Bakker, S. J. L., & Navis, G. J. (2006) · Kidney International · doi:10.1038/sj.ki.5002011 · Cited by 100
Yang, P., Xiao, Y., Luo, X., Zhao, Y., Zhao, L., Wang, Y., Wu, T., Li, W., & Chen, Y. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m076216 · Cited by 100
Managing dyslipidemia in chronic kidney disease
Weiner, D. E., & Sarnak, M. J. (2004) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2004.40049.x · Cited by 95
Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice
Gai, Z., Gui, T., Hiller, C., & Kullak-Ublick, G. A. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.694323 · Cited by 93
Self-citationGai, Z., Visentin, M., Gui, T., Zhao, L., Thasler, W. E., Häusler, S., Hartling, I., Cremonesi, A., Hiller, C., & Kullak-Ublick, G. A. (2018) · Molecular Pharmacology · doi:10.1124/mol.117.111047 · Cited by 91
Self-citationConcise Review: Adipocyte Origins: Weighing the Possibilities
Majka, S. M., Barak, Y., & Klemm, D. J. (2011) · Stem Cells · doi:10.1002/stem.653 · Cited by 91
Short-Term Changes after a Weight Reduction Intervention in Advanced Diabetic Nephropathy
Friedman, A. N., Chambers, M., Kamendulis, L. M., & Temmerman, J. C. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04010413 · Cited by 91
Asghari, G., Farhadnejad, H., Mirmiran, P., Dizavi, A., Yuzbashian, E., & Azizi, F. (2016) · Hypertension Research · doi:10.1038/hr.2016.98 · Cited by 91
Asghari, G., Yuzbashian, E., Mirmiran, P., & Azizi, F. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw273 · Cited by 91
Luiken, J. J. F. P., Chanda, D., Nabben, M., Neumann, D., & Glatz, J. F. C. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.09.004 · Cited by 90
Dietary pattern and incidence of chronic kidney disease among adults: a population-based study
Asghari, G., Momenan, M., Yuzbashian, E., Mirmiran, P., & Azizi, F. (2018) · Nutrition & Metabolism · doi:10.1186/s12986-018-0322-7 · Cited by 89
Effects of Mediterranean Diets on Kidney Function: A Report From the PREDIMED Trial
Díaz‐López, A., Bulló, M., Martínez‐González, M. Á., Guasch‐Ferré, M., Ros, E., Basora, J., Covas, M., López‐Sabater, M. C., & Salas‐Salvadó, J. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.02.334 · Cited by 86
Protective effect of thymol on high fat diet induced diabetic nephropathy in C57BL/6J mice
Saravanan, S., & Pari, L. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.11.033 · Cited by 85
Lin, W., Zhang, Q., Liu, L., Yin, S., Liu, Z., & Cao, W. (2017) · Kidney International · doi:10.1016/j.kint.2017.02.023 · Cited by 85
Thorne, R. F., Ralston, K. J., de Bock, C. E., Mhaidat, N. M., Zhang, X. D., Boyd, A., & Burns, G. F. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.07.002 · Cited by 84
Ferraro, P. M., Ferraccioli, G., Gambaro, G., Fulignati, P., & Costanzi, S. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn454 · Cited by 83
Farnesoid X receptor activation protects the kidney from ischemia-reperfusion damage
Gai, Z., Chu, L., Xu, Z., Song, X., Sun, D., & Kullak-Ublick, G. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-10168-6 · Cited by 82
Self-citationCD36 in Atherosclerosis: The Role of a Class B Macrophage Scavenger Receptor
NICHOLSON, A. C., Febbraio, M., Han, J., et al. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06307.x · Cited by 81
Matsusue, K., Gavrilova, O., Lambert, G. C., Brewer, H. B., Ward, J. M., Inoue, Y., LeRoith, D., & Gonzalez, F. J. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0213 · Cited by 80
Bile acid receptors and the kidney
Herman‐Edelstein, M., Weinstein, T., & Levi, M. (2017) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000374 · Cited by 75
Zhou, J., & Wei‐jie, Y. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.03.012 · Cited by 74
Okamura, D. M., López-Guisa, J. M., Koelsch, K., Collins, S., & Eddy, A. A. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00063.2007 · Cited by 74
Adeosun, S. O., Gordon, D. M., Weeks, M. F., Moore, K. H., Hall, J. E., Hinds, T. D., & Stec, D. E. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00495.2017 · Cited by 73
Lynes, M. D., Narisawa, S., Millán, J. L., & Widmaier, E. P. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00235.2011 · Cited by 73
Souza, A. C. P., Bocharov, A. V., Baranova, I. N., Vishnyakova, T. G., Huang, Y. G., Wilkins, K. J., Hu, X., Street, J. M., Álvarez-Prats, A., Mullick, A. E., et al. (2016) · Kidney International · doi:10.1016/j.kint.2015.12.043 · Cited by 73
Fatty acid transport proteins in disease: New insights from invertebrate models
Dourlen, P., Sujkowski, A. L., Wessells, R. J., & Mollereau, B. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.08.001 · Cited by 71
Human mesangial cells express inducible macrophage scavenger receptor
Ruan, X. Z., Varghese, Z., Powis, S. H., & Moorhead, J. F. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00587.x · Cited by 69
Zhang, J., Mulumba, M., Ong, H., & Lubell, W. D. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201611685 · Cited by 69
Dai, D., Chang, Y., Chen, Y., Chen, S., Yu, S., Guo, X., & Sun, Y. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13121231 · Cited by 68
Thrombospondin-1 plays a profibrotic and pro-inflammatory role during ureteric obstruction
Bigé, N., Shweke, N., Benhassine, S., Jouanneau, C., Vandermeersch, S., Dussaule, J., Chatziantoniou, C., Ronco, P. M., & Boffa, J. (2012) · Kidney International · doi:10.1038/ki.2012.21 · Cited by 67
Arıcı, M. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.10.1751 · Cited by 66
Scavenging new insights into atherogenesis
de Winther, M. P. J., & Hofker, M. H. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9919 · Cited by 63
Mazaraki, A., Tsioufis, C. P., Dimitriadis, K. S., Tsiachris, D., Stefanadi, E., Zampelas, A., Richter, D. J., Mariolis, A., Panagiotakos, D. B., Tousoulis, D., et al. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2010.244 · Cited by 63
Miller, E. R., Juraschek, S. P., Anderson, C. A. M., Güallar, E., Henoch-Ryugo, K., Charleston, J. B., Turban, S., BENNETT, M. R., & Appel, L. J. (2012) · Diabetes Care · doi:10.2337/dc12-1940 · Cited by 63
Cho, H., Um, J., Lee, J., Kim, W., Kang, W. S., Kim, S. H., Ha, H., Kim, Y., Ahn, Y., Jung, D., et al. (2017) · Scientific Reports · doi:10.1038/srep44186 · Cited by 63
Bessi, V. L., Labbé, S. M., Huynh, D. N., Ménard, L., Jossart, C., Febbraio, M., Guérin, B., Bentourkia, M., Lecomte, R., Carpentier, A. C., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs225 · Cited by 60
Iorio, B. R. D., Micco, L. D., Marzocco, S., Simone, E. D., Blasio, A. D., Sirico, M. L., Nardone, L., & On behalf of UBI Study Group (2017) · Nutrients · doi:10.3390/nu9010069 · Cited by 60
Association of Vegetarian Diet with Chronic Kidney Disease
Liu, H.-W., Tsai, W., Liu, J., & Kuo, K. (2019) · Nutrients · doi:10.3390/nu11020279 · Cited by 56
Regulation of granulocyte and monocyte differentiation by CCAAT/enhancer binding protein α
Friedman, A. D., Keefer, J. R., Kummalue, T., Liu, H., Wang, Q., & Cleaves, R. (2003) · Blood Cells Molecules and Diseases · doi:10.1016/s1079-9796(03)00135-9 · Cited by 52
Petrescu, A. D., Huang, H., Martin, G. G., McIntosh, A. L., Storey, S. M., Landrock, D., Kier, A. B., & Schroeder, F. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00334.2012 · Cited by 52
Zhang, Y.-Y., Li, X., Qian, S., Guo, L., Huang, H.-Y., He, Q., Liu, Y., Ma, C.-G., & Tang, Q.-Q. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-11-0912 · Cited by 52
DASH dietary pattern and chronic kidney disease in elderly Korean adults
Lee, H. S., Lee, K. B., Hyun, Y. Y., Chang, Y., Ryu, S., & Choi, Y. (2016) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.240 · Cited by 51
Dietary interventions to improve outcomes in chronic kidney disease
Goraya, N., & Wesson, D. E. (2015) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000160 · Cited by 50
Omega-3 Fatty Acid Supplementation in Advanced Kidney Disease
Friedman, A. N. (2010) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2010.00748.x · Cited by 49
Wang, C., Hu, L. T., Zhao, L., Yang, P., Moorhead, J. F., Varghese, Z., Chen, Y., & Ruan, X. Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103071 · Cited by 49
Obesity in kidney disease: A heavyweight opponent
Felizardo, R. J. F., da Silva, M. B., Aguiar, C. F., & Câmara, N. O. S. (2014) · World Journal of Nephrology · doi:10.5527/wjn.v3.i3.50 · Cited by 48
Zanetti, M., Cappellari, G. G., Barbetta, D., Semolic, A., & Barazzoni, R. (2017) · Nutrients · doi:10.3390/nu9080895 · Cited by 48
Gertow, K., Rosell, M., Sjögren, P., Eriksson, P. O., Vessby, B., Fairé, U. D., Hamsten, A., Hellénius, M.-L., & Fisher, R. M. (2006) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602471 · Cited by 46
Gibbs, P., Lerner‐Marmarosh, N., Poulin, A., Farah, E. N., & Maines, M. D. (2014) · The FASEB Journal · doi:10.1096/fj.13-247015 · Cited by 44
Atgl deficiency induces podocyte apoptosis and leads to glomerular filtration barrier damage
Chen, W., Jiang, Y., Han, J., Hu, J., He, T., Yan, T., Huang, N., Zhang, Q., Mei, H., Liao, Y., et al. (2017) · FEBS Journal · doi:10.1111/febs.14038 · Cited by 41
Precision toxicology shows that troxerutin alleviates ochratoxin A–induced renal lipotoxicity
Yang, X., Xu, W., Huang, K., Zhang, B., Wang, H., Zhang, X., Gong, L., Luo, Y., & He, X. (2018) · The FASEB Journal · doi:10.1096/fj.201800742r · Cited by 40
Effects of Fish Oil Supplementation on Kidney Transplantation
Tatsioni, A., Chung, M. C., Sun, Y., Kupelnick, B., Lichtenstein, A. H., Perrone, R. D., Chew, P. W., Lau, J. T. F., & Bonis, P. A. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005020176 · Cited by 39
Ren, Y., Wang, D., Lu, F., Zou, X., Xu, L., Wang, K., Huang, W., Su, H., Zhang, C., Gao, Y., et al. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.05.019 · Cited by 38
Dysregulation of hepatic fatty acid metabolism in chronic kidney disease
Jin, K., Norris, K. C., & Vaziri, N. D. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs350 · Cited by 37
Intracellular Transport of Fatty Acids in Muscle
Glatz, J. F. C., van Breda, E., & Vusse, G. J. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-1928-1_19 · Cited by 36
Gertow, K., Skoglund-Andersson, C., Eriksson, P. O., Boquist, S., Orth‐Gomér, K., Schenck-Gustafsson, K. G., Hamsten, A., & Fisher, R. M. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(02)00454-9 · Cited by 36
Guthmann, F., Maehl, P., Preiß, J., Kolleck, I., & Rüstow, B. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/pl00012522 · Cited by 35
Bocharov, A. V., Wu, T., Baranova, I. N., Birukova, A. A., Sviridov, D. O., Vishnyakova, T. G., Remaley, A. T., Eggerman, T. L., Patterson, A. P., & Birukov, K. G. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1401028 · Cited by 35
Gao, X., WU, J., Qian, Y., Fu, L., Wu, G., Xu, C., & Mei, C. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1799 · Cited by 34
Effect of Statins on Renal Function in Chronic Kidney Disease Patients
Hu, P., Wu, M., Lin, T.-C., Chen, T.-T., Wu, Y., Su, S., Lu, K., Chen, J.-S., Sung, F.-C., Lee, C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-34632-z · Cited by 34
Fish Oil Treatment for Kidney Transplant Recipients: A Meta-Analysis of Randomized Controlled Trials
Lim, A. K. H., Manley, K. J., Roberts, M. A., & Fraenkel, M. B. (2007) · Transplantation · doi:10.1097/01.tp.0000258613.32993.84 · Cited by 30
Yamada, Y., Matsui, K., Takeuchi, I., & Fujimaki, T. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2152 · Cited by 29
Stieger, B., Mahdi, Z., & Jäger, W. R. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-105010 · Cited by 29
Interaction of thrombospondin1 and CD36 contributes to obesity-associated podocytopathy
Cui, W., Maimaitiyiming, H., Zhou, Q., Norman‐Burgdolf, H., Zhou, C., & Wang, S. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.03.010 · Cited by 28
Acyl-CoA binding protein and epidermal barrier function
Bloksgaard, M., Neess, D., Færgeman, N. J., & Mandrup, S. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.09.013 · Cited by 21
Effects of omega-3 fatty acids on organ transplantation.
Bonis, P. A. L., Chung, M., Tatsioni, A., Sun, Y., Kupelnick, B., Lichtenstein, A. H., Perrone, R. D., Chew, P. W., DeVine, D., & Lau, J. T. F. (2005) · PubMed · Cited by 20
Sterol carrier protein‐2:Not just for cholesterol any more
Murphy, E. J. (2002) · Molecular and Cellular Biochemistry · doi:10.1023/a:1020580706912 · Cited by 18
Chao, C., Chen, Y., Chiang, C., Huang, J., Fang, C., Chang, C.-C., & Yen, C. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8516748 · Cited by 17
Yamamoto, M., Shimizu, Y., Takahashi, H., Yajima, H., Yokoyama, Y., Ishigami, K., Tabeya, T., Suzuki, C., Matsui, M., Naishiro, Y., et al. (2014) · Modern Rheumatology · doi:10.3109/14397595.2014.950826 · Cited by 17
Mechanisms of Intracellular Fatty Acid Transport: Role of Cytoplasmic-Binding Proteins
Weisiger, R. A. (2007) · Journal of Molecular Neuroscience · doi:10.1007/s12031-007-0047-y · Cited by 16
Ahn, S. Y., Kim, D. K., Han, S. S., Park, J. H., Shin, S. J., Lee, S. H., Choi, B. S., Lim, C. S., Kim, S., & Chin, H. J. (2018) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.2018.37.1.49 · Cited by 16
Hsieh, C.-F., Chang, H.-C., Huang, S., Chen, C., Chen, W., & Yang, C. (2017) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2017/5632195 · Cited by 15
Xiao, X., Li, H., Yang, J., Qi, X., Zu, X., Yang, J. L., Zhong, J., Cao, R., Liu, J., & Wen, G.-B. (2014) · Steroids · doi:10.1016/j.steroids.2014.03.004 · Cited by 13
Visentin, M., Biason, P., & Toffoli, G. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.05.005 · Cited by 13
Self-citationLee, H. W., Lee, S. M., Lee, M., Son, Y. K., Kim, S. E., & An, W. S. (2018) · Marine Drugs · doi:10.3390/md16110398 · Cited by 12
Jiang, Y.-H., Jiang, L.-Y., Wu, S., Jiang, W., Xie, L., Li, W., & Yang, C.-H. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00304 · Cited by 7
Dual PPARα/γAgonism Normalizes Lipoprotein Profile of Renal Dyslipidemia
Samuelsson, O. G., Attman, P.-O., Gause‐Nilsson, I. A. M., Svensson, M. K. E., & Alaupovic, P. (2013) · PPAR Research · doi:10.1155/2013/391628 · Cited by 4
Cited by
Signaling pathways of chronic kidney diseases, implications for therapeutics
Yuan, Q., Tang, B., & Zhang, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01036-5 · Cited by 453
Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities
Opazo-Ríos, L., Mas, S., Marín-Royo, G., Mezzano, S., Gómez-Guerrero, C., Moreno, J. A., & Egido, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072632 · Cited by 363
Bayır, H., Dixon, S. J., Tyurina, Y. Y., Kellum, J. A., & Kagan, V. E. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00689-x · Cited by 331
Obesity and chronic kidney disease
Jiang, Z., Wang, Y., Zhao, X., Cui, H., Han, M., Ren, X., Gang, X., & Wang, G. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00179.2022 · Cited by 267
Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function
Brennan, E., Kantharidis, P., Cooper, M. E., & Godson, C. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-021-00454-y · Cited by 262
Metadata
- Authors
- Gai, Z., Wang, T., Visentin, M., Kullak-Ublick, G., Fu, X., & Wang, Z.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2019-03-28
- Volume
- 11
- Issue
- 4
- Pages
- 722
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2923389938
- Cited by
- 421
- References
- 177
- FWCI
- 24.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.